Comment
doi: 10.1016/j.jhep.2021.10.023.
Epub 2021 Nov 5.
Reply to: "NAFLD vs. MAFLD - It is not the name but the disease that decides the outcome in fatty liver"
Affiliations
- PMID: 34748894
- DOI: 10.1016/j.jhep.2021.10.023
Item in Clipboard
Comment
Reply to: "NAFLD vs. MAFLD - It is not the name but the disease that decides the outcome in fatty liver"
J Hepatol.
2022 Feb.
No abstract available
Conflict of interest statement
Conflict of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment on
-
Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States.J Hepatol. 2021 Dec;75(6):1284-1291. doi: 10.1016/j.jhep.2021.07.035. Epub 2021 Aug 8. J Hepatol. 2021. PMID: 34380057
-
NAFLD vs. MAFLD - It is not the name but the disease that decides the outcome in fatty liver.J Hepatol. 2022 Feb;76(2):475-477. doi: 10.1016/j.jhep.2021.09.002. Epub 2021 Sep 14. J Hepatol. 2022. PMID: 34530064 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
